Move over fellas; the condom aisle isn’t just for men anymore. Well, it never was really, but as retail pharmacies become more adept at discreetly merchandising intimacy health — remember when the pharmacist had to pull the condom display from behind the counter? — there is a trend developing toward marketing condoms with the female buyer in mind.
What is the CVS Health competitive edge? To answer that question, CVS Health president and CEO Larry Merlo took the stage Wednesday during the UBS Global Healthcare Conference, a three-day conference in New York City that brings together investors and more than 200 companies across a variety of healthcare sectors.
As the country’s healthcare system continues to move away from a fee-for-service structure, retail-based clinics are taking on added significance for the operators of these facilities and their patients.
Is there a niche OTC opportunity on which food, drug and mass retailer pharmacies are not fully capitalizing? If the answer isn’t yes, then the cat is already out of the bag — according to the American Pet Products Association the market for pet supplies and OTC medicines will grow by 4.7% by the end of the year.
A new and radically different concept for frontline health care emerged last year when Walmart unveiled its first Walmart Care Clinics in Texas, Georgia and South Carolina. If things go according to plan, patients and health plan payers across the United States can look forward to a cheaper and more affordable alternative to the family doctor for nearly all their primary care needs.
The retail behemoth that is Wal-Mart Stores Inc. is fixing its sights on a new target: the nation’s overstretched and overly costly primary healthcare system. The result could be a major disruption of that system and the acceleration of health reform in America.
While building a 4,500-store retail pharmacy powerhouse in the United States, Walmart also has kept pace with the specialty pharmacy revolution and is positioning itself to play a stronger role in this most innovative, dynamic and complex area of pharmaceutical R&D and bioengineering.
Drug Store News on Sunday caught up with Brian McNamara, region head of Europe and the Americas of the recently christened GSK Consumer Healthcare, representing the joint venture between GlaxoSmithKline and Novartis to talk about what a consolidating OTC market means for the industry, and how GSK will be coming to market.
Self-service kiosks got a nod from the Millennial generation, as a new survey released by location-based mobile platform Retale showed that 20% of Millennial shoppers don’t like interacting with cashiers at checkout.